thisdrug what a medicine's name tells you

WHO naming stem · suffix · 62 listed names

-caine

This page was written with AI.

local anaesthetics

WHO's definition, quoted as written in the 2024 stem book

13 of 62 names appear in these lists: 13 in the US list (FDA Drugs@FDA) and 3 in the EU central list (EMA); 16 have national brands in at least one EU/EEA country.

Names only. This page is about -caine as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -caine. So the letters caine sit at the end of the name (…caine).

All 62 names WHO lists under -caine

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 13 of 62 names appear in these lists: 13 in the US list (FDA Drugs@FDA) and 3 in the EU central list (EMA); 16 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. ambucaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. amoxecaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. aptocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. articaine
    US brands: CYKLX (discontinued in FDA listings)
    in combination: ORABLOC with epinephrine; SEPTOCAINE with epinephrine; ULTACAN (discontinued in FDA listings) with epinephrine; ULTACAN FORTE (discontinued in FDA listings) with epinephrine
    EU (central) brands: none found
  5. benzocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. betoxycaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. bucricaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. bumecaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. bupivacaine
    US brands: EXPAREL, MARCAINE, MARCAINE HYDROCHLORIDE, MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, SENSORCAINE, BUPIVACAINE LIPOSOME (discontinued in FDA listings), POSIMIR (discontinued in FDA listings), XARACOLL (discontinued in FDA listings)
    in combination: MARCAINE HYDROCHLORIDE W/ EPINEPHRINE with epinephrine; MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE with epinephrine; SENSORCAINE with epinephrine; VIVACAINE with epinephrine; ZYNRELEF KIT with meloxicam; DUOCAINE (discontinued in FDA listings) with lidocaine
    EU (central) brands: Exparel liposomal
    in combination: Zynrelef (withdrawn) with meloxicam
  10. butacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. butanilicaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. carticaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. chloroprocaine
    US brands: IHEEZO, NESACAINE, NESACAINE-MPF, CLOROTEKAL (discontinued in FDA listings)
    EU (central) brands: none found
  14. cinchocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. clibucaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. clodacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. clormecaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. cyclomethycaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. dexivacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. diamocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. edronocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. elucaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. etidocaine
    US brands: DURANEST (discontinued in FDA listings)
    in combination: DURANEST (discontinued in FDA listings) with epinephrine
    EU (central) brands: none found
  24. fexicaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. fomocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. hexylcaine
    US brands: CYCLAINE (discontinued in FDA listings)
    EU (central) brands: none found
  27. hydroxyprocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. hydroxytetracaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  29. ipravacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  30. ketocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. leucinocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. levobupivacaine
    US brands: CHIROCAINE (discontinued in FDA listings)
    EU (central) brands: none found
  33. lidocaine
    US brands: AKTEN, BONDLIDO, GLYDO, LARYNG-O-JET KIT, LIDOCAINE HYDROCHLORIDE VISCOUS, LIDOCAINE VISCOUS, LIDODERM, XYLOCAINE, ZTLIDO, ALPHACAINE (discontinued in FDA listings), ALPHACAINE HYDROCHLORIDE (discontinued in FDA listings), ANESTACON (discontinued in FDA listings)
    10 moreDENTIPATCH (discontinued in FDA listings), LARYNGOTRACHEAL ANESTHESIA KIT (discontinued in FDA listings), LIDOCATON (discontinued in FDA listings), LIDOPEN (discontinued in FDA listings), LTA II KIT (discontinued in FDA listings), PEDIATRIC LTA KIT (discontinued in FDA listings), XYLOCAINE DENTAL (discontinued in FDA listings), XYLOCAINE PRESERVATIVE FREE (discontinued in FDA listings), XYLOCAINE VISCOUS (discontinued in FDA listings), ZINGO (discontinued in FDA listings)
    in combination: FLAVALTA with epinephrine; LIGNOSPAN FORTE with epinephrine; LIGNOSPAN STANDARD with epinephrine; ORAQIX with prilocaine; PLIAGLIS with tetracaine; XYLOCAINE W/ EPINEPHRINE with epinephrine; ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE (discontinued in FDA listings) with epinephrine; DECADRON W/ XYLOCAINE (discontinued in FDA listings) with dexamethasone; DUOCAINE (discontinued in FDA listings) with bupivacaine; EMBOLEX (discontinued in FDA listings) with dihydroergotamine + heparin; EMLA (discontinued in FDA listings) with prilocaine; IONTOCAINE (discontinued in FDA listings) with epinephrine
    8 moreLANABIOTIC (discontinued in FDA listings) with bacitracin + neomycin + polymyxin b; LIDOCATON (discontinued in FDA listings) with epinephrine; LIDOSITE TOPICAL SYSTEM KIT (discontinued in FDA listings) with epinephrine; OCTOCAINE (discontinued in FDA listings) with epinephrine; ROCEPHIN KIT (discontinued in FDA listings) with ceftriaxone; SYNERA (discontinued in FDA listings) with tetracaine; TERRAMYCIN (discontinued in FDA listings) with oxytetracycline; XYLOCAINE DENTAL WITH EPINEPHRINE (discontinued in FDA listings) with epinephrine
    EU (central) brands, in combination: Fortacin with prilocaine; Senstend (withdrawn) with prilocaine
  34. lotucaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  35. mepivacaine
    US brands: POLOCAINE, POLOCAINE-MPF, SCANDONEST PLAIN, ARESTOCAINE HYDROCHLORIDE (discontinued in FDA listings), CARBOCAINE (discontinued in FDA listings), ISOCAINE HYDROCHLORIDE (discontinued in FDA listings)
    in combination: ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN (discontinued in FDA listings) with levonordefrin; CARBOCAINE W/ NEO-COBEFRIN (discontinued in FDA listings) with levonordefrin; ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN (discontinued in FDA listings) with levonordefrin; POLOCAINE W/ LEVONORDEFRIN (discontinued in FDA listings) with levonordefrin; SCANDONEST L (discontinued in FDA listings) with levonordefrin
    EU (central) brands: none found
  36. meprylcaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  37. myrtecaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  38. octacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  39. oxetacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  40. oxybuprocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  41. paridocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  42. phenacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  43. pinolcaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  44. pramocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  45. pribecaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  46. prilocaine
    US brands: CITANEST (discontinued in FDA listings), CITANEST PLAIN (discontinued in FDA listings), CITANEST PLAIN DENTAL (discontinued in FDA listings)
    in combination: CITANEST FORTE DENTAL with epinephrine; ORAQIX with lidocaine; CITANEST FORTE (discontinued in FDA listings) with epinephrine; EMLA (discontinued in FDA listings) with lidocaine
    EU (central) brands, in combination: Fortacin with lidocaine; Senstend (withdrawn) with lidocaine
  47. procaine
    US brands: NOVOCAIN (discontinued in FDA listings)
    in combination: ACHROMYCIN (discontinued in FDA listings) with tetracycline; RAVOCAINE AND NOVOCAIN W/ LEVOPHED (discontinued in FDA listings) with norepinephrine + propoxycaine; RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN (discontinued in FDA listings) with levonordefrin + propoxycaine; TETRACYN (discontinued in FDA listings) with tetracycline
    EU (central) brands: none found
  48. propanocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  49. propipocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  50. propoxycaine
    US brands, in combination: RAVOCAINE AND NOVOCAIN W/ LEVOPHED (discontinued in FDA listings) with norepinephrine + procaine; RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN (discontinued in FDA listings) with levonordefrin + procaine
    EU (central) brands: none found
  51. proxymetacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  52. pyrrocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  53. quatacaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  54. quinisocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  55. risocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  56. rodocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  57. ropivacaine
    US brands: NAROPIN
    EU (central) brands: none found
  58. tetracaine
    US brands, in combination: KOVANAZE with oxymetazoline; PLIAGLIS with lidocaine; SYNERA (discontinued in FDA listings) with lidocaine
    EU (central) brands: none found
  59. tolycaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  60. trapencaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  61. trimecaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  62. vadocaine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Same group, without the stem

WHO also lists these 4 names under -caine: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. They belong to the same group of substances as the group (a) names above, yet they do not carry -caine, so the name alone does not reveal the group.

  1. amolanone
  2. cryofluorane
  3. dyclonine
  4. midamaline

Decode another name

Decoded

elucaine

Listed INNCarries 2 WHO stems, most specific first: -caine …

  • -caineend of the nameWHO lists it hereWHO definition: local anaesthetics
  • -cain-inside the nameWHO definition: class I antiarrhythmics, procainamide and lidocaine derivatives

“elucaine” is an INN that WHO lists under -caine in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -caine (Part II B) and the 62 names (Part IV, group (a)), and the 4 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy